{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T07:08:02Z","timestamp":1706512082570},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2005,8,23]],"date-time":"2005-08-23T00:00:00Z","timestamp":1124755200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1007\/s00198-005-1975-4","type":"journal-article","created":{"date-parts":[[2005,8,22]],"date-time":"2005-08-22T15:50:06Z","timestamp":1124725806000},"page":"212-216","source":"Crossref","is-referenced-by-count":5,"title":["Hospitalization-related bone loss and the protective effect of risedronate"],"prefix":"10.1007","volume":"17","author":[{"given":"Robert P.","family":"Heaney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Valent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian P.","family":"Barton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,8,23]]},"reference":[{"key":"1975_CR1","unstructured":"Whedon GD, Heaney RP (1991) Effects of physical inactivity, paralysis, and weightlessness. In: Hall B (ed) Bone, vol. 7. CRC Press, Boca Raton, FL, USA, pp 57\u201377"},{"key":"1975_CR2","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/0026-0495(70)90032-6","volume":"19","author":"Donaldson","year":"1970","unstructured":"Donaldson CL, Hulley SB, Vogel JM, Hattner RS, Bayers JH, McMillan DE (1970) Effect of prolonged bed rest on bone mineral. Metabolism 19:1071\u20131084","journal-title":"Metabolism"},{"key":"1975_CR3","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/jbmr.5650050807","volume":"5","author":"LeBlanc","year":"1990","unstructured":"LeBlanc AD, Schneider VS, Evans HJ, Engelbretson DA, Krebs JM (1990) Bone mineral loss and recovery after 17 weeks of bed rest. J Bone Miner Res 5:843\u2013850","journal-title":"J Bone Miner Res"},{"key":"1975_CR4","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1042\/cs0640537","volume":"64","author":"Kr","year":"1983","unstructured":"Kr\u00f8lner B, Toft B (1983) Vertebral bone loss: an unheeded side effect of therapeutic bed rest. Clin Sci 64:537\u2013540","journal-title":"Clin Sci"},{"key":"1975_CR5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJM200102013440503","volume":"344","author":"McClung","year":"2001","unstructured":"McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, Adami S, Fogelman I, Diamond T, Eastell R, Meunier PJ, Reginster JY for the Hip Intervention Program Study Group (2001) Effect of risedronate on the risk of hip fracture in elderly women. New Engl J Med 344:333\u2013340","journal-title":"New Engl J Med"},{"key":"1975_CR6","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","volume":"282","author":"Harris","year":"1999","unstructured":"Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M, Chesnut CH 3rd, Brown J, Eriksen EF, Hoseyni MS, Axelrod DW, Miller PD for the Vertebral Efficacy with Risedronate Therapy (VERT) Study Group (1999) Effects of risedronate treatment on vertebral and non-vertebral fractures in women with postmenopausal osteoporosis. A randomized controlled trial. JAMA 282:1344\u20131352","journal-title":"JAMA"},{"key":"1975_CR7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s001980050010","volume":"11","author":"Reginster","year":"2000","unstructured":"Reginster J, Minne HW, Sorensen OH, Hooper M, Roux C, Brandi ML, Lund B, Ethgen D, Pack S, Roumagnac I, Eastell R for the Vertebral Efficacy with Risedronate Therapy (VERT) Study Group (2000) Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Osteoporos Int 11:83\u201391","journal-title":"Osteoporos Int"},{"key":"1975_CR8","unstructured":"McClung M, Bensen W, Bolognese M, Bonnick S, Ettinger M, Harris S, Knecht T, Lang R, Miller P, Pavlov E, Silverman S, Woodson G, Faulkner K, Ethgen D, Axelrod D (1998) Risedronate increases bone mineral density at the hip, spine and radius in postmenopausal women with low bone mass [Abstract]. Osteoporos Int 8 [Suppl 3]:111"},{"key":"1975_CR9","first-page":"1895","volume":"85","author":"Fogelman","year":"2000","unstructured":"Fogelman I, Ribot C, Smith R, Ethgen D, Sod E, Reginster JY (2000) Risedronate reverses bone loss in postmenopausal women with low bone mass: results from a multinational, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 85:1895\u20131900","journal-title":"J Clin Endocrinol Metab"},{"key":"1975_CR10","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s00223-002-1022-9","volume":"71","author":"Soininvaara","year":"2002","unstructured":"Soininvaara TA, Jurvelin JS, Miettinen HJA, Suomalainen OT, Alhava EM, Kroeger PJ (2002) Effect of alendronate on periprosthetic bone loss after total knee arthroplasty: a 1-year, randomized, controlled trial of 19 patients. Calcif Tissue Int 71:472\u2013477","journal-title":"Calcif Tissue Int"},{"key":"1975_CR11","first-page":"335","volume":"2","author":"LeBlanc","year":"2002","unstructured":"LeBlanc AD, Driscol TB, Shackelford LC, Evans HJ, Rianon NJ, Smith SM, Feeback DL, Lai D (2002) Alendronate as an effective countermeasure to disuse induced bone loss. J Musculoskelet Neuronal Interact 2:335\u2013343","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"1975_CR12","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1359\/jbmr.2000.15.3.586","volume":"15","author":"Van","year":"2000","unstructured":"Van der Poest Clement E, Patka P, Vandormael K, Haarman H, Lips P (2000) The effect of alendronate on bone mass after distal forearm fracture. J Bone Miner Res 15:586\u2013593","journal-title":"J Bone Miner Res"},{"key":"1975_CR13","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/jbmr.5650100420","volume":"10","author":"Ruml","year":"1995","unstructured":"Ruml LA, Dubois SK, Roberts ML, Pak CYC (1995) Prevention of hypercalciuria and stone-forming propensity during prolonged bed rest by alendronate. J Bone Miner Res 10:655\u2013662","journal-title":"J Bone Miner Res"},{"key":"1975_CR14","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/jbmr.5650100116","volume":"10","author":"Chappard","year":"1995","unstructured":"Chappard D, Minaire P, Privat C, Berard E, Mendoza-Sarmiento J, Tournebise H, Basle MF, Audran M, Rebel A, Picot C, Gaud C (1995) Effects of tiludronate on bone loss in paraplegic patients. J Bone Miner Res 10:112\u2013118","journal-title":"J Bone Miner Res"},{"key":"1975_CR15","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/0026-0495(89)90226-6","volume":"38","author":"Chappard","year":"1989","unstructured":"Chappard D, Alexandre C, Palle S, Vico L, Morukov BV, Rodionova SS, Minaire P, Riffat G (1989) Effects of a bisphosphonate (1-hydroxy ethylidene-1,1 bisphosphonic acid) on osteoclast number during prolonged bed rest in healthy humans. Metab Clin Exp 38:822\u2013825","journal-title":"Metab Clin Exp"},{"key":"1975_CR16","unstructured":"Minaire P, Depassio J, Berard E, Meunier PJ, Edouard C, Pilonchery G, Goedert G (1987) Effects of clodronate on immobilization bone loss. Bone 8 [Suppl 1]:S63\u2013S68"},{"key":"1975_CR17","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1210\/jcem-41-3-533","volume":"41","author":"Lockwood","year":"1975","unstructured":"Lockwood DR, Vogel JM, Schneider VS, Hulley SB (1975) Effect of the diphosphonate EHDP on bone mineral metabolism during prolonged bed rest. J Clin Endocrinol Metab 41:533\u2013541","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-005-1975-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-005-1975-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-005-1975-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T06:17:36Z","timestamp":1706509056000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-005-1975-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,23]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["1975"],"URL":"https:\/\/doi.org\/10.1007\/s00198-005-1975-4","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8,23]]}}}